Saliva and inhibition of HIV‐1 infection: molecular mechanisms
- 4 July 2002
- journal article
- review article
- Published by Wiley in Oral Diseases
- Vol. 8 (s2), 169-175
- https://doi.org/10.1034/j.1601-0825.8.s2.7.x
Abstract
Oral fluids are rarely a vehicle for HIV-1 infection in vivo, unlike other mucosal secretions. This unique property raises questions regarding (1) the molecular mechanisms responsible for the lack of salivary transmission, (2) the extent to which oral immunological responses mirror responses at other mucosal sites, (3) the use of promising salivary markers of HIV-1 disease progression, (4) the relationship between oral and blood viral loads, (5) cofactors that influence oro-genital transmission, and (6) the feasibility of oral-based antibody testing for HIV-1 diagnosis in the home. This paper discusses these questions and provides background summaries, findings from new studies, consensus opinions, practical relevance to developing countries, and suggestions for future research agenda on each of the key topics.Keywords
This publication has 50 references indexed in Scilit:
- Salivary calprotectin levels are raised in patients with oral candidiasis or Sjögren’s syndrome but decreased by HIV infectionOral Microbiology and Immunology, 2001
- Oral transmission of HIVAIDS, 1998
- Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type 1Oral Diseases, 1997
- Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV‐1Oral Diseases, 1997
- Human Submandibular Saliva Specifically Inhibits HIV Type 1AIDS Research and Human Retroviruses, 1997
- Impact of Streptococcus pneumoniae Bacteremia and Human Immunodeficiency Virus Type 1 on Oral Mucosal ImmunityThe Journal of Infectious Diseases, 1995
- Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.Journal of Clinical Investigation, 1995
- A Modified ELISA and Western Blot Accurately Determine Anti-Human Immunodeficiency Virus Type 1 Antibodies in Oral Fluids Obtained with a Special Collecting DeviceThe Journal of Infectious Diseases, 1995
- Oral Candidiasis Is Associated with Low Levels of Parotid Calprotectin in Individuals with Infection Due to Human Immunodeficiency VirusClinical Infectious Diseases, 1993
- A TH1→TH2 switch is a critical step in the etiology of HIV infectionImmunology Today, 1993